Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16769953.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors performed a retrospective cohort comparison using the Nationwide Inpatient Sample for 1999 through 2002 of acute ischemic stroke admissions. Mortality was compared based on the use of thrombolysis. Hospital mortality was significantly greater for the thrombolysis cohort (10.1% vs 5.8%) as was the rate of secondary intracranial hemorrhage (4.2% vs 0.4%). US community experience in the use of thrombolysis has higher rates of complications and mortality than in controlled clinical trials.
Medical subject headings
- Inpatients
- Risk Assessment
- Stroke
- Thrombolytic Therapy
- Tissue Plasminogen Activator